DecisionView raises $9M for clinical-trial software
San Francisco’s DecisionView, which sells software that helps biotech and pharmaceutical companies run clinical trials more efficiently, raised $9 million in a third round of funding. The round was led by firstVentury, a new investor joined by Partech International and Granite Ventures.
From the company’s release:
The funding will be used to scale its commercial growth capabilities and expand DecisionView’s suite of clinical performance optimization applications, including the company’s innovative clinical recruitment platform, StudyOptimizer™. As the industry’s first business performance optimization application for clinical trials, StudyOptimizer automates the recruitment process with integrated predictive modeling, simulation, planning, and rich visualization capabilities. The company was also recently named in the list of “Cool Vendors” in the “Cool Vendors in Life Sciences, 2007″ report by Gartner, Inc.
Next Story: NowPublic, citizen journalism site, expands with $10.6M
Previous Story: TheFunded further embraces VCs, but Sequoia still hazed
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
